Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-12-003418
Filing Date
2012-04-10
Accepted
2012-04-10 08:44:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G/A 7909
  Complete submission text file 0000315066-12-003418.txt   9542
Mailing Address 82 DEVONSHIRE STREET BOSTON MA 02109
Business Address 82 DEVONSHIRE ST BOSTON MA 02109 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 061209781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

EIN.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81457 | Film No.: 12750791
SIC: 2836 Biological Products, (No Diagnostic Substances)